Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Fenofibric Acid Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Fenofibric Acid Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 45 mg Delayed Release Capsules
      • 1.3.3 135 mg Delayed Release Capsules
    • 1.4 Market Segment by Application
      • 1.4.1 Global Fenofibric Acid Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Drug store
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Fenofibric Acid Market Size
      • 2.1.1 Global Fenofibric Acid Revenue 2014-2025
      • 2.1.2 Global Fenofibric Acid Sales 2014-2025
    • 2.2 Fenofibric Acid Growth Rate by Regions
      • 2.2.1 Global Fenofibric Acid Sales by Regions 2014-2019
      • 2.2.2 Global Fenofibric Acid Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Fenofibric Acid Sales by Manufacturers
      • 3.1.1 Fenofibric Acid Sales by Manufacturers 2014-2019
      • 3.1.2 Fenofibric Acid Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Fenofibric Acid Revenue by Manufacturers (2014-2019)
      • 3.2.2 Fenofibric Acid Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Fenofibric Acid Market Concentration Ratio (CR5 and HHI)
    • 3.3 Fenofibric Acid Price by Manufacturers
    • 3.4 Key Manufacturers Fenofibric Acid Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Fenofibric Acid Market
    • 3.6 Key Manufacturers Fenofibric Acid Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 45 mg Delayed Release Capsules Sales and Revenue (2014-2019)
      • 4.1.2 135 mg Delayed Release Capsules Sales and Revenue (2014-2019)
    • 4.2 Global Fenofibric Acid Sales Market Share by Type
    • 4.3 Global Fenofibric Acid Revenue Market Share by Type
    • 4.4 Fenofibric Acid Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Fenofibric Acid Sales by Application

    6 United States

    • 6.1 United States Fenofibric Acid Breakdown Data by Company
    • 6.2 United States Fenofibric Acid Breakdown Data by Type
    • 6.3 United States Fenofibric Acid Breakdown Data by Application

    7 European Union

    • 7.1 European Union Fenofibric Acid Breakdown Data by Company
    • 7.2 European Union Fenofibric Acid Breakdown Data by Type
    • 7.3 European Union Fenofibric Acid Breakdown Data by Application

    8 China

    • 8.1 China Fenofibric Acid Breakdown Data by Company
    • 8.2 China Fenofibric Acid Breakdown Data by Type
    • 8.3 China Fenofibric Acid Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Fenofibric Acid Breakdown Data by Company
    • 9.2 Rest of World Fenofibric Acid Breakdown Data by Type
    • 9.3 Rest of World Fenofibric Acid Breakdown Data by Application
    • 9.4 Rest of World Fenofibric Acid Breakdown Data by Countries
      • 9.4.1 Rest of World Fenofibric Acid Sales by Countries
      • 9.4.2 Rest of World Fenofibric Acid Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 AbbVie
      • 10.1.1 AbbVie Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Fenofibric Acid
      • 10.1.4 Fenofibric Acid Product Introduction
      • 10.1.5 AbbVie Recent Development
    • 10.2 Lupin
      • 10.2.1 Lupin Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Fenofibric Acid
      • 10.2.4 Fenofibric Acid Product Introduction
      • 10.2.5 Lupin Recent Development
    • 10.3 Impax Laboratories
      • 10.3.1 Impax Laboratories Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Fenofibric Acid
      • 10.3.4 Fenofibric Acid Product Introduction
      • 10.3.5 Impax Laboratories Recent Development
    • 10.4 Mylan
      • 10.4.1 Mylan Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Fenofibric Acid
      • 10.4.4 Fenofibric Acid Product Introduction
      • 10.4.5 Mylan Recent Development
    • 10.5 Alembic Pharmaceuticals
      • 10.5.1 Alembic Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Fenofibric Acid
      • 10.5.4 Fenofibric Acid Product Introduction
      • 10.5.5 Alembic Pharmaceuticals Recent Development
    • 10.6 Par Pharmaceutical
      • 10.6.1 Par Pharmaceutical Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Fenofibric Acid
      • 10.6.4 Fenofibric Acid Product Introduction
      • 10.6.5 Par Pharmaceutical Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Fenofibric Acid Sales Channels
      • 11.2.2 Fenofibric Acid Distributors
    • 11.3 Fenofibric Acid Customers

    12 Market Forecast

    • 12.1 Global Fenofibric Acid Sales and Revenue Forecast 2019-2025
    • 12.2 Global Fenofibric Acid Sales Forecast by Type
    • 12.3 Global Fenofibric Acid Sales Forecast by Application
    • 12.4 Fenofibric Acid Forecast by Regions
      • 12.4.1 Global Fenofibric Acid Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Fenofibric Acid Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Fenofibric acid is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. It works by increasing the natural substance (enzyme) that breaks down fats in the blood.
      In 2019, the market size of Fenofibric Acid is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fenofibric Acid.

      This report studies the global market size of Fenofibric Acid, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Fenofibric Acid sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      AbbVie
      Lupin
      Impax Laboratories
      Mylan
      Alembic Pharmaceuticals
      Par Pharmaceutical
      ...

      Market Segment by Product Type
      45 mg Delayed Release Capsules
      135 mg Delayed Release Capsules

      Market Segment by Application
      Hospital
      Drug store

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Fenofibric Acid status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Fenofibric Acid manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Fenofibric Acid are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now